News

Filter

Current filters:

Chelsea Therapeutics

1 to 9 of 15 results

Lundbeck to complete Chelsea Thera acquisition today

Lundbeck to complete Chelsea Thera acquisition today

23-06-2014

Danish CNS specialist Lundbeck says that it has completed the tender offer to buy all of the outstanding…

Chelsea TherapeuticsLundbeckMergers & AcquisitionsNeurologicalNortheraPharmaceutical

Lundbeck in deal to acquire Chelsea Therapeutics

Lundbeck in deal to acquire Chelsea Therapeutics

08-05-2014

Danish CNS specialist Lundbeck revealed today that it has entered into a definitive agreement to acquire…

BiotechnologyChelsea TherapeuticsLundbeckMergers & AcquisitionsNeurologicalNorthera

FDA approves Northera for neurogenic orthostatic hypotension

FDA approves Northera for neurogenic orthostatic hypotension

19-02-2014

Shares of US biotech firm Chelsea Therapeutics soared 38% to $6.75 in after-hours trading yesterday,…

BiotechnologyChelsea TherapeuticsDainippon Sumitomo PharmaNorth AmericaNortheraRare diseasesRegulationUSA

Chelsea Therapeutics names Joseph Oliveto as president and CEO

Chelsea Therapeutics names Joseph Oliveto as president and CEO

27-01-2014

US biotech firm Chelsea Therapeutics’ (Nasdaq: CHTP) has named Joseph Oliveto as president and chief…

BiotechnologyBoardroomChelsea TherapeuticsUSA

Surprise FDA advisory panel backing for Chelsea’s Northera

Surprise FDA advisory panel backing for Chelsea’s Northera

15-01-2014

A US Food and Drug Administration advisory panel has voted 16-one to recommend approval of US biotech…

BiotechnologyCardio-vascularChelsea TherapeuticsNorth AmericaNortheraRegulationUSA

US FDA further delays Chelsea's Northera

29-07-2013

US biotech firm Chelsea Therapeutics (Nasdaq: CHTP) has received acknowledgment of its resubmitted New…

BiotechnologyCardio-vascularChelsea TherapeuticsNorth AmericaNortheraRegulation

Chelsea Therapeutics resubmits NDA for Northera to the US FDA

10-07-2013

US biotech firm Chelsea Therapeutics (Nasdaq: CHTP) has resubmitted a New Drug Application to the US…

Cardio-vascularChelsea TherapeuticsNortheraPharmaceuticalRegulation

Chelsea Thera to re-file Northera NDA with existing data; Celgene share buyback

21-02-2013

Chelsea Therapeutics International (Nasdaq: CHTP) saw its shares more than double to $1.61 in pre-market…

BiotechnologyCardio-vascularCelgeneChelsea TherapeuticsFinancialNorth AmericaNortheraRegulation

1 to 9 of 15 results

COMPANY SPOTLIGHT

Menarini

Back to top